BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38009743)

  • 1. UBE2R2-AS1, as a prognostic marker of gastric cancer, promotes the malignant phenotype of gastric cancer cells.
    Xu J; Xiao M; Huang Z; Chen Z; Lin J
    Histol Histopathol; 2024 Jun; 39(6):739-745. PubMed ID: 38009743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway.
    Wu Z; Wei ZH; Chen SH
    Cell Cycle; 2020 Oct; 19(19):2426-2435. PubMed ID: 32835579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer.
    Wang F; Zhao M; Jiang Y; Xia S; Sun D; Zhou D; Dong Z
    Histol Histopathol; 2023 Jun; 38(6):637-645. PubMed ID: 35916204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUBE2R2-AS1 as Prognostic Marker, Promotes Cell Migration and Invasion in Non-Small Cell Lung Cancer by Modulating Epithelial-Mesenchymal Transition Process.
    Liu X; Liao B; Wang L; Lu L; Yao W; Chen M
    Ann Clin Lab Sci; 2022 May; 52(3):462-469. PubMed ID: 35777800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma.
    Xu W; Che DD; Chen L; Lv SQ; Su J; Tan J; Liu Q; Pan YW
    J Mol Neurosci; 2021 Aug; 71(8):1605-1613. PubMed ID: 33528791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer.
    Liu F; Cui J; Xue D
    Tohoku J Exp Med; 2023 Sep; 261(1):13-23. PubMed ID: 36792178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA
    Liu C; Li H; Yin Q
    Open Med (Wars); 2020; 15(1):1184-1192. PubMed ID: 33336075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA UBE2R2-AS1 promotes glioma cell apoptosis via targeting the miR-877-3p/TLR4 axis.
    Xu W; Hu GQ; Da Costa C; Tang JH; Li QR; Du L; Pan YW; Lv SQ
    Onco Targets Ther; 2019; 12():3467-3480. PubMed ID: 31123407
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion.
    Song Z; Wang J
    Bioengineered; 2022 Jan; 13(1):1507-1517. PubMed ID: 34986743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer.
    Li Z; Liu X; Luo N; Pang Y; Hou Y; Jiang G
    Bioengineered; 2021 Dec; 12(2):12931-12939. PubMed ID: 34852705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis.
    Liang C; Yue C; Liang C; Ge H; Wei Z; Li G; Wu J; Huang H; Guo J
    Onco Targets Ther; 2019; 12():8879-8893. PubMed ID: 31802900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
    Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
    Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
    Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p.
    Dang Y; Ouyang X; Ren W; Wang L; Huang Q
    Cancer Manag Res; 2021; 13():5163-5175. PubMed ID: 34234560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis.
    Li M; Cai O; Tan S
    Onco Targets Ther; 2019; 12():11345-11357. PubMed ID: 31908498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
    Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY
    DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
    Li C; Wu R; Xing Y
    Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1.
    Chen S; Wang J
    Cancer Cell Int; 2019; 19():353. PubMed ID: 31889905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.